Form 4: Aurinia Pharmaceuticals Director Sells Shares to Cover Tax Obligations

Jill Leversage, a director at Aurinia Pharmaceuticals, sold 5,610 shares of common stock on May 21, 2024, to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Summary

• On May 21, 2024, Jill Leversage, a director of Aurinia Pharmaceuticals Inc. (AUPH), sold 5,610 shares of common stock.
• The sale was executed at a price of $5.74 per share.
• This transaction was conducted to cover tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs) granted on May 19, 2023.
• Following the transaction, Leversage directly owns 12,918 shares of Aurinia Pharmaceuticals Inc.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (selling shares to cover taxes on vested stock). It doesn't contain information that would significantly shift sentiment positively or negatively.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and directors. This transaction is a routine financial activity and doesn't necessarily indicate a change in the director's confidence in the company.

Stakeholder Impact

• The sale of shares by a director could have a minor impact on shareholder sentiment, but is unlikely to have a significant effect given the context of covering tax obligations.

Key Dates